The historical rank and industry rank for DanCann Pharma AS's Days Payable or its related term are showing as below:
STU:DAN0'
s Days Payable Range Over the Past 10 Years
Min: 57.58 Med: 87 Max: 188.04
Current: 97
During the past 7 years, DanCann Pharma AS's highest Days Payable was 188.04. The lowest was 57.58. And the median was 87.00.
STU:DAN0's Days Payable is not ranked
in the Drug Manufacturers industry.
Industry Median: 90.61
vs STU:DAN0: 97.00
DanCann Pharma AS's Days Payable
increased
from Sep. 2024 (87.35) to Sep. 2025 (124.57).
It may suggest that DanCann Pharma ASdelayed paying its suppliers.
DanCann Pharma AS Days Payable Related Terms
DanCann Pharma AS Days Payable Historical Data
* Premium members only.
The historical data trend for DanCann Pharma AS's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:DAN0 vs ZTS, UTHR, RGC: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, DanCann Pharma AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DanCann Pharma AS Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DanCann Pharma AS's Days Payable distribution charts can be found below:
* The bar in red indicates where DanCann Pharma AS's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
DanCann Pharma AS's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DanCann Pharma AS (STU:DAN0) has a Days Payable of 124.57 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on DanCann Pharma AS and its competitors. This is 43% above median its historical median of 87.00. Over the past decade, DanCann Pharma AS's Days Payable has ranged from 57.58 to 188.04.
Is DanCann Pharma AS's Days Payable too high?
DanCann Pharma AS's current Days Payable of 124.57 is 43% above median its 10-year median of 87.00. Over the past 10 years, this metric has ranged from a low of 57.58 to a high of 188.04. The Drug Manufacturers industry median Days Payable is 90.61. DanCann Pharma AS's value of 124.57 is 37.5% above this industry median. Overall, DanCann Pharma AS has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does DanCann Pharma AS's Days Payable compare to ZTS and UTHR?
DanCann Pharma AS's Days Payable of 124.57 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.61. DanCann Pharma AS's value of 124.57 is 37.5% above this benchmark. Historically, DanCann Pharma AS's own Days Payable has ranged from 57.58 to 188.04 over the past decade. While the company's 10-year median is 87.00 vs. the industry median of 90.61, DanCann Pharma AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.61, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DanCann Pharma AS's current Days Payable of 124.57 is 37.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on DanCann Pharma AS and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DanCann Pharma AS's current Days Payable is 124.57, which is 43% above median its own 10-year median of 87.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DanCann Pharma AS stock overvalued right now?
DanCann Pharma AS (STU:DAN0) has a current Days Payable of 124.57. The current Days Payable is 124.57, which is 43% above median its 10-year median of 87.00 and 37.5% above the Drug Manufacturers industry median of 90.61. DanCann Pharma AS's overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For DanCann Pharma AS (STU:DAN0), the current Days Payable is 124.57 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.
27GF Score
Get the complete analysis for STU:DAN0
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:DAN0 has been successfully added to your 
